autism spectrum disorder AND parental mental and physical distress autism spectrum disorder AND parental mental and physical distress
Conditions
Interventions
Theraplay is a directive play intervention based on the attachment theory. It is a semi structured treatment method. Before every Theraplay trajectory a MIM-NL-II trajectory is performed. This is a st
observation specifically developed to set the goals within the Theraplay trajectory. In response to the MIM-NL-II the content of the Theraplay sessions will be composed. The Theraplay goals are discus
whether the Theraplay trajectory will be continued or finished depending on the goals being achieved. An average Theraplay trajectory lasts 26 sessions, approximately 8 months.
Treatment as usual (TA
Sponsors
Parnassia
Eligibility
Age
2 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. Primary diagnoses of autism spectrum disorder. Children with a developmental delay, mental retardation or co-morbid psychiatric disorders, which are often found in children with autism, can be included. 2. Children aged from 3 to 6 years old. 3. Child and parents understand Dutch and can communicate in Dutch without interpreter.
Exclusion criteria
Exclusion criteria: 1. Start of new psychiatric medication within three months before the start of the study. Medication use for longer periods can be continued. Medication can be stopped during the study. 2. Following another concurrent psychological treatment at the same time elsewhere. 3. Child and/or parent(s) have followed any kind of play therapay or play intervention in the past.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Is Theraplay an effective treatment method for children with ASD and what is the effect of a treatment with Theraplay on their parents? | — |
Secondary
| Measure | Time frame |
|---|---|
| The effectiveness of Theraplay on 1) the parent-child relationship between children with ASD and their parents, 2) psychiatric problems, such as internalizing and/or externalizing behavioural problems and autism specific traits within the child, 3) parental mental and 4) physical distress, 5) the use of hair cortisol as a potential biomarker for treatment effectiveness, 6) a decrease of the immunological and microbiological consequences of chronic stress 7) the use of immunological and microbiome measurements as biomarkers of chronic stress 8) the use of immunological and microbiome measurements as biomarkers of treatment effectiveness. | — |
Countries
Netherlands
Contacts
Public ContactH. Swaab
Universiteit Leiden
Outcome results
None listed